{"generic":"Folic Acid","drugs":["FA-8","Folacin-800","Folic Acid","Nature's Blend Folic Acid","ViloFane-Dp 7.5"],"mono":{"0":{"id":"237230-s-0","title":"Generic Names","mono":"Folic Acid"},"1":{"id":"237230-s-1","title":"Dosing and Indications","sub":[{"id":"237230-s-1-4","title":"Adult Dosing","mono":"<ul><li><b>Folic acid deficiency:<\/b> up to 1 mg\/day IM, IV, ORAL, SC; resistant cases may require larger doses<\/li><li><b>Folic acid deficiency:<\/b> maintenance, 0.4 mg\/day ORALLY; for pregnant and lactating women, 0.8 mg\/day ORALLY; never less than 0.1 mg\/day<\/li><li><b>Homocystinemia:<\/b> 0.5 to 5 mg\/day ORALLY<\/li><li><b>Megaloblastic anemia:<\/b> up to 1 mg\/day IM, IV, ORAL, SC; resistant cases may require larger doses<\/li><li><b>Megaloblastic anemia:<\/b> maintenance, 0.4 mg\/day ORAL, for pregnant and lactating women, 0.8 mg\/day; never less than 0.1 mg\/day<\/li><li><b>Pregnancy vitamin\/iron prophylaxis:<\/b> 0.4 mg to 1 mg ORALLY per day<\/li><li><b>Recommended dietary allowance:<\/b> men, 400 mcg\/day; women, 400 mcg\/day; pregnancy 600 mcg\/day; lactation, 500 mcg\/day ORALLY<\/li><li><b>Toxicity of drug, Methotrexate:<\/b> 5 to 27.5 mg\/wk ORALLY<\/li><\/ul>"},{"id":"237230-s-1-5","title":"Pediatric Dosing","mono":"<ul><li><b>Folic acid deficiency:<\/b> ORAL, IM, IV, SC, up to 1 mg\/day; resistant cases may require larger doses<\/li><li><b>Folic acid deficiency:<\/b> maintenance, infants, 0.1 mg\/day; age under 4 y, up to 0.3 mg\/day; age  4 y or older, 0.4 mg\/day<\/li><li><b>Megaloblastic anemia:<\/b> ORAL, IM, IV, SC, up to 1 mg\/day; resistant cases may require larger doses<\/li><li><b>Megaloblastic anemia:<\/b> maintenance, infants, 0.1 mg\/day; age under 4 y, up to 0.3 mg\/day; age 4 y or older, 0.4 mg\/day<\/li><li><b>Recommended dietary allowance:<\/b> 1 y and younger, 65 to 80 mcg\/day; 1 to 3 y, 150 mcg\/day; 4 to 8 y, 200 mcg\/day; 9 to 13 y, 300 mcg\/day; 14 to 18 y, 400 mcg\/d ORALLY<\/li><\/ul>"},{"id":"237230-s-1-6","title":"Dose Adjustments","mono":"<ul><li><b>alcoholism, hemolytic anemia:<\/b> maintenance dose may need to be increased<\/li><li><b>anticonvulsant therapy, chronic infection:<\/b> maintenance dose may need to be increased<\/li><\/ul>"},{"id":"237230-s-1-7","title":"Indications","mono":"<b>FDA-Labeled Indications<\/b><br\/>Megaloblastic anemia<br\/><b>Non-FDA Labeled Indications<\/b><ul><li>Age-related cognitive decline; Prophylaxis<\/li><li>Antiepileptic adverse reaction - Folic acid deficiency<\/li><li>Folic acid deficiency<\/li><li>Folic acid deficiency - Sex hormones adverse reaction<\/li><li>Homocystinemia<\/li><li>Pregnancy vitamin\/iron prophylaxis<\/li><li>Recommended dietary allowance<\/li><li>Toxicity of drug, Methotrexate<\/li><\/ul>"}]},"3":{"id":"237230-s-3","title":"Contraindications\/Warnings","sub":[{"id":"237230-s-3-9","title":"Contraindications","mono":"hypersensitivity to folic acid products<br\/>"},{"id":"237230-s-3-10","title":"Precautions","mono":"<ul><li>folic acid doses above 0.1 mg\/day may obscure pernicious anemia (hematologic remission while neurological manifestations progress)<\/li><li>pernicious anemia and other megaloblastic anemias caused by vitamin B12 deficiency<\/li><\/ul>"},{"id":"237230-s-3-11","title":"Pregnancy Category","mono":"<ul><li>A (FDA)<\/li><li>A (AUS)<\/li><\/ul>"},{"id":"237230-s-3-12","title":"Breast Feeding","mono":"<ul><li>AAP: Maternal medication usually compatible with breastfeeding.<\/li><li>WHO: Compatible with breastfeeding.<\/li><li>Micromedex: Infant risk is minimal.<\/li><\/ul>"}]},"4":{"id":"237230-s-4","title":"Drug Interactions","sub":{"1":{"id":"237230-s-4-14","title":"Major","mono":"<ul><li>Dasabuvir (theoretical)<\/li><li>Paritaprevir (theoretical)<\/li><\/ul>"},"2":{"id":"237230-s-4-15","title":"Moderate","mono":"<ul><li>Fosphenytoin (probable)<\/li><li>Phenytoin (probable)<\/li><li>Tea (probable)<\/li><\/ul>"}}},"5":{"id":"237230-s-5","title":"Adverse Effects","mono":"<b>Common<\/b><ul><li><b>Gastrointestinal:<\/b>Bad taste in mouth, Large doses, Loss of appetite, Nausea<\/li><li><b>Neurologic:<\/b>Confusion<\/li><li><b>Psychiatric:<\/b>Irritability, Sleep pattern disturbance<\/li><\/ul><b>Serious<\/b><br\/><b>Immunologic:<\/b>Allergic condition<br\/>"},"6":{"id":"237230-s-6","title":"Drug Name Info","sub":{"0":{"id":"237230-s-6-17","title":"US Trade Names","mono":"<ul><li>FA-8<\/li><li>Folacin-800<\/li><li>Nature's Blend Folic Acid<\/li><li>ViloFane-Dp 7.5<\/li><\/ul>"},"2":{"id":"237230-s-6-19","title":"Class","mono":"<ul><li>Nutriceutical<\/li><li>Nutritive Agent<\/li><li>Vitamin B (class)<\/li><\/ul>"},"3":{"id":"237230-s-6-20","title":"Regulatory Status","mono":"RX\/OTC<br\/>"},"4":{"id":"237230-s-6-21","title":"Generic Availability","mono":"Yes<br\/>"}}},"7":{"id":"237230-s-7","title":"Mechanism Of Action","mono":"Systemic: Folic acid, after conversion to tetrahydrofolic acid, is necessary for normal erythropoiesis , synthesis of purine and thymidylates , metabolism of amino acids such as glycine and methionine,   and the metabolism of histidine.  <br\/>"},"8":{"id":"237230-s-8","title":"Pharmacokinetics","sub":{"0":{"id":"237230-s-8-23","title":"Absorption","mono":"Systemic: Almost complete<br\/>"},"2":{"id":"237230-s-8-25","title":"Metabolism","mono":"Systemic: Hepatic: Active metabolite: tetrahydrofolic acid <br\/>"},"3":{"id":"237230-s-8-26","title":"Excretion","mono":"Systemic: Renal <br\/>"}}},"10":{"id":"237230-s-10","title":"Monitoring","mono":"<ul><li>symptomatic improvement, CBC, serum folate<\/li><li>(injection) aluminum toxicity; in renal impairment and premature neonates<\/li><\/ul>"},"11":{"id":"237230-s-11","title":"How Supplied","mono":"<ul><li><b>Generic<\/b><br\/><ul><li>Injection Solution: 5 MG\/ML<\/li><li>Oral Capsule: 5 MG, 20000 MCG<\/li><li>Oral Tablet: 0.4 MG, 0.8 MG, 1 MG, 800 MCG<\/li><\/ul><\/li><li><b>FA-8<\/b><br\/>Oral Capsule: 800 MCG<br\/><\/li><li><b>Folacin-800<\/b><br\/>Oral Tablet: 0.8 MG<br\/><\/li><li><b>Methylfolate<\/b><br\/>Oral Capsule: 2000 MCG<br\/><\/li><li><b>Nature's Blend Folic Acid<\/b><br\/>Oral Tablet: 1 MG<br\/><\/li><li><b>Optimum Folic Acid<\/b><br\/>Oral Tablet: 800 MCG<br\/><\/li><li><b>PharmAssure Folic Acid<\/b><br\/>Oral Tablet: 0.4 MG, 0.8 MG<br\/><\/li><li><b>Rite Aid Folic Acid<\/b><br\/>Oral Tablet: 0.4 MG<br\/><\/li><\/ul>"},"13":{"id":"237230-s-13","title":"Clinical Teaching","mono":"<ul><li>This drug may cause loss of appetite, nausea, confusion, irritability, or sleep-pattern disturbance. Large doses of drug may cause bad taste in mouth.<\/li><li>Patient should not drink alcohol while taking this drug.<\/li><\/ul>"}}}